Fenofibrate Tablets — Class III drug recall D-1211-2018
Terminated recall by Hetero Labs, Ltd. - Unit III, reported 2018-10-03, distributed in IN, LA. Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bot
| Recall number | D-1211-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hetero Labs, Ltd. - Unit III, Hyderabad, India |
| Recall initiated | 2018-09-12 |
| Classified | 2018-09-25 |
| Reported by FDA | 2018-10-03 |
| Terminated | 2018-11-29 |
| Distributed | IN, LA |
| Quantity | 5,424 bottles |
| NDC | 31722-0595, 31722-0595-30, 31722-0595-31, 31722-0595-32, 31722-0595-90, 31722-0596, 31722-0596-30, 31722-0596-31, 31722-0596-32, 31722-0596-90 |
| Lot numbers | E181370 |
| Expiration dates | 2020-05 |
Product
Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90
Reason for recall
Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1211-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.